Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients

Published:2018-02 Issue:1 Volume:40 Page:52-58
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Felipe Claudia,Ferreira Alexandra,Bessa Adrieli,Abait Tamiris,Perez Juliana D.,Casarini Dulce Elena,Medina-Pestana Jose,Tedesco Helio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. Reduced incidence of cytomegalovirus infection in kidney transplant recipients receiving everolimus and reduced tacrolimus doses;Tedesco-Silva;Am J Transpl.,2015

2. 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients;Tedesco-Silva;Transpl Int.,2007

3. Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients;Tedesco Silva;Am J Transpl.,2010

4. Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine;Shihab;Clin Transplant.,2013

5. Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation;Langer;Transpl Int.,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of NR1I2 and ABCB1 Genetic Polymorphisms on Everolimus Pharmacokinetics in Japanese Renal Transplant Patients;International Journal of Molecular Sciences;2022-10-03

2. Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients;Journal of Clinical Pharmacy and Therapeutics;2022-08-07

3. Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donor;Transplant International;2019-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3